Greg Elson

Vice President Biologics Manufacturing at Glenmark Pharmaceuticals Limited

Location:
Glenmark House B D S Marg Chakala Off Western Express Highway, Mumbai, Maharashtra, India
Company:
Glenmark Pharmaceuticals Limited
HQ Phone:
+91 22 4018 9999
Wrong Greg Elson?

Last Updated 2/15/2017

General Information

Employment History

Head of Manufacturing Department  - Novimmune SA

Research Scientist  - GlaxoSmithKline plc

Education

Ph.D.  - field of Molecular Immunology , GlaxoSmithKline

PhD  - Molecular Immunology , University of Manchester

Web References  

Bispecific Antibody Therapeutics

Greg Elson, Ph.D., Vice President, Biologics Manufacturing, Glenmark Pharmaceuticals

Read More
Speaker Biographies

Greg Elson, Ph.D., Vice President, Biologics Manufacturing, Glenmark Pharmaceuticals
Dr. Greg Elson obtained his Ph.D. in the field of Molecular Immunology working as a research scientist at GSK before joining Geneva biotech start up NovImmune in 2001. He created a Bioprocessing department focused on the transition of innovative antibody products into clinical development. In 2013, Greg joined the biologics division of Glenmark Pharmaceuticals in Neuchatel, Switzerland where he heads a manufacturing department of close to 40 people dedicated to bringing novel Mab, bispecific and biosimilar products through the pre-clinical and clinical development path.

Read More
NovImmune -- Research & Development Leads

(l-r) Walter Ferlin, Nicolas Fischer, and Greg Elson
Scientific research and manufacturing operations at NovImmune are directed by our Chief Scientific Officer, Marie Kosco-Vilbois, and led by department heads Nicolas Fischer, Walter Ferlin, and Greg Elson. Greg Elson Head of Manufacturing With a PhD in Molecular Immunology from the University of Manchester, Greg Elson has been working in biotech product discovery and development for over fifteen years, starting out at GlaxoSmithKline on the identification and characterization of novel cytokines and receptors. He has been at NovImmune since early 2001, initially in therapeutic product discovery and preclinical development. Over the past eight years, Greg has progressively focused on bioprocess development for NovImmune's 7 therapeutic products, and now heads up the manufacturing department with expertise in expression technology development, upstream processes (USP), downstream processes (DSP), analytical development, and quality control.

Read More

Browse ZoomInfo’s Directories